M
MIVI Neuroscience
MIVI Neuroscience, Inc. is focused on developing and commercializing superior clinical solutions for neurointerventional procedures
About MIVI Neuroscience
MIVI Neuroscience, Inc. specializes in developing and commercializing advanced clinical solutions for neurointerventional procedures. The company offers a range of innovative devices designed to improve patient outcomes by minimizing complications, shortening procedure times, and expanding treatment options to a broader patient base. MIVI Neuroscience operates in the medical device industry, specifically targeting neurointerventional procedures, which involve minimally invasive techniques to treat conditions affecting the brain and central nervous system. The company's primary clients are physicians and healthcare providers who perform these specialized procedures. MIVI Neuroscience's business model revolves around the research, development, and commercialization of its proprietary devices. Revenue is generated through the sale of these devices to hospitals, clinics, and medical professionals. The company is headquartered in Eden Prairie, Minnesota, USA, and continues to focus on innovation to maintain its competitive edge in the neurointerventional market. Keywords: neurointerventional, medical devices, patient outcomes, complications, procedure times, treatment expansion, healthcare providers, innovation, commercialization, minimally invasive.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Eden Prairie, United States
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 56.5/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Neurology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning MIVI Neuroscience.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Jun 2024 | $9.3M | — | Undisclosed | ↗ |
| SERIES B✓Equity / VC | Jan 2021 | $35M | $140M | Concord Health Partners · Deerfield · Aphelion Capital · Perceptive Advisors | — |
Growth signals
Latest recorded traffic for MIVI Neuroscience is 1.9K monthly website visits, down 5% over the last three months. MIVI Neuroscience's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Concord Health Partners- ACAphelion Capital
Perceptive Advisors
Series B and later1 investor entered at this stage
Deerfield
Other known investors1 additional known investor
Ben Constable
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about MIVI Neuroscience on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MIVI Neuroscience’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.